Zentiva SA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: ROSCDBACNOR8
RON
4.52
4.52 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Sep'23
Net Sales
271.35
289.06
273.74
284.96
266.30
269.09
233.94
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
271.35
289.06
273.74
284.96
266.30
269.09
233.94
Raw Material Cost
175.44
172.64
177.59
174.93
157.75
156.06
154.47
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
52.09
52.51
50.60
53.83
45.51
43.66
39.59
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.77
2.02
1.52
0.81
0.66
1.73
0.81
Selling and Distribution Expenses
37.50
41.79
35.95
36.56
29.28
34.95
28.21
Other Expenses
-5.29
-5.45
-5.21
-5.46
-4.62
-4.54
-4.04
Total Expenditure (Excl Depreciation)
212.95
214.43
213.54
211.49
187.04
191.01
182.68
Operating Profit (PBDIT) excl Other Income
58.4
74.6
60.199999999999996
73.5
79.3
78.1
51.3
Other Income
10.75
10.41
13.40
8.59
10.52
10.08
9.79
Operating Profit (PBDIT)
74.65
71.14
74.48
85.44
93.16
90.03
66.05
Interest
0.77
2.02
1.52
0.81
0.66
1.73
0.81
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
95.90
116.42
96.15
110.04
108.54
113.02
79.47
Depreciation
9.05
10.29
6.92
6.58
7.44
7.91
8.98
Profit Before Tax
64.83
58.82
66.04
78.04
85.06
80.40
56.26
Tax
9.60
10.35
7.03
9.18
10.89
11.65
4.75
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
55.23
48.48
59.01
68.86
74.17
68.75
51.52
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
55.23
48.48
59.01
68.86
74.17
68.75
51.52
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
55.23
48.48
59.01
68.86
74.17
68.75
51.52
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.1
0.1
0.1
0.1
0.1
0.1
0.1
Reserves
1,496.81
1,441.59
1,392.85
1,333.85
1,265.43
1,191.26
1,123.22
Earnings per share (EPS)
0.08
0.07
0.08
0.1
0.11
0.1
0.07
Diluted Earnings per share
0.08
0.07
0.08
0.1
0.11
0.1
0.07
Operating Profit Margin (Excl OI)
20.22%
17.45%
19.79%
24.66%
28.24%
26.77%
20.21%
Gross Profit Margin
27.23%
23.91%
26.65%
29.7%
34.73%
32.82%
27.89%
PAT Margin
20.35%
16.77%
21.56%
24.16%
27.85%
25.55%
22.02%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2025 is -6.16% vs 5.63% in Dec 2024

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2025 is 13.81% vs -17.80% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2025 is 5.27% vs -0.65% in Dec 2024

stock-summary

Interest

QoQ Growth in quarter ended Mar 2025 is -60.00% vs 33.33% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2025 has improved from Dec 2024

Compare Quarterly Results Of Zentiva SA With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(RON)
Change(%)
Net Sales
271.35
95.08
176.27
185.39%
Other Operating Income
0.00
0.00
0.00
Total Operating income
271.35
95.08
176.27
185.39%
Raw Material Cost
175.44
37.77
137.67
364.50%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
52.09
13.86
38.23
275.83%
Power Cost
0
0
0.00
Manufacturing Expenses
0.77
0.00
0.77
Selling and Distribution Expenses
37.50
19.49
18.01
92.41%
Other Expenses
-5.29
-1.39
-3.90
-280.58%
Total Expenditure (Excl Depreciation)
212.95
57.27
155.68
271.84%
Operating Profit (PBDIT) excl Other Income
58.40
37.81
20.59
54.46%
Other Income
10.75
1.08
9.67
895.37%
Operating Profit (PBDIT)
74.65
42.23
32.42
76.77%
Interest
0.77
0.00
0.77
Exceptional Items
0.00
-0.04
0.04
100.00%
Gross Profit (PBDT)
95.90
57.31
38.59
67.34%
Depreciation
9.05
4.27
4.78
111.94%
Profit Before Tax
64.83
37.91
26.92
71.01%
Tax
9.60
5.59
4.01
71.74%
Provisions and contingencies
0
0
0.00
Profit After Tax
55.23
32.33
22.90
70.83%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
55.23
32.33
22.90
70.83%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
55.23
32.33
22.90
70.83%
Equity Capital
0
0
0.00
Face Value
0.10
0.10
0.00
Reserves
1,496.81
510.59
986.22
193.15%
Earnings per share (EPS)
0.08
0.00
0.08
Diluted Earnings per share
0.08
0.00
0.08
Operating Profit Margin (Excl OI)
20.22%
38.79%
0.00
-18.57%
Gross Profit Margin
27.23%
44.37%
0.00
-17.14%
PAT Margin
20.35%
34.00%
0.00
-13.65%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 27.13 Million
in Mar 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2025 is -6.16% vs 5.63% in Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 is 1.88% vs 15.43% in Mar 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 5.52 Million
in Mar 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2025 is 13.81% vs -17.80% in Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 is -25.61% vs 73.77% in Mar 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6.39 Million
in Mar 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2025 is 5.27% vs -0.65% in Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 is -22.64% vs 66.87% in Mar 2024

Quarterly - Interest
Interest 0.08 Million
in Mar 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2025 is -60.00% vs 33.33% in Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 is 14.29% vs -22.22% in Mar 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.22%
in Mar 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2025 has improved from Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 has fallen from Mar 2024